Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1984 1
1985 1
1986 3
1988 1
1990 1
1992 1
1994 3
1995 4
1996 1
1997 2
1998 4
1999 1
2000 3
2001 3
2002 3
2003 1
2004 1
2006 5
2007 3
2008 3
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Beta2 déjà vu.
O'Byrne PM, Adelroth E. O'Byrne PM, et al. Among authors: adelroth e. Chest. 2006 Jan;129(1):3-5. doi: 10.1378/chest.129.1.3. Chest. 2006. PMID: 16424402 No abstract available.
Drug trials.
Adelroth E, Barnes NC, Chung KF, Davies RJ, Poulter LW. Adelroth E, et al. Eur Respir J Suppl. 1998 Mar;26:36S-38S. Eur Respir J Suppl. 1998. PMID: 9585879 Review. No abstract available.
Reassessing the Th2 cytokine basis of asthma.
O'Byrne PM, Inman MD, Adelroth E. O'Byrne PM, et al. Among authors: adelroth e. Trends Pharmacol Sci. 2004 May;25(5):244-8. doi: 10.1016/j.tips.2004.03.008. Trends Pharmacol Sci. 2004. PMID: 15120489 Review.
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.
Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, Burney P, Chanez P, Connett G, Corrigan C, de Blic J, Fabbri L, Holgate ST, Ind P, Joos G, Kerstjens H, Leuenberger P, Lofdahl CG, McKenzie S, Magnussen H, Postma D, Saetta M, Salmeron S, Sterk P. Chung KF, et al. Among authors: adelroth e. Eur Respir J. 1999 May;13(5):1198-208. doi: 10.1034/j.1399-3003.1999.13e43.x. Eur Respir J. 1999. PMID: 10414427 Free article. Review. No abstract available.
The effect of omalizumab on nasal allergic inflammation.
Plewako H, Arvidsson M, Petruson K, Oancea I, Holmberg K, Adelroth E, Gustafsson H, Sandström T, Rak S. Plewako H, et al. Among authors: adelroth e. J Allergy Clin Immunol. 2002 Jul;110(1):68-71. doi: 10.1067/mai.2002.125488. J Allergy Clin Immunol. 2002. PMID: 12110823 Clinical Trial.
Diesel exhaust enhances airway responsiveness in asthmatic subjects.
Nordenhäll C, Pourazar J, Ledin MC, Levin JO, Sandström T, Adelroth E. Nordenhäll C, et al. Among authors: adelroth e. Eur Respir J. 2001 May;17(5):909-15. doi: 10.1183/09031936.01.17509090. Eur Respir J. 2001. PMID: 11488325 Free article.
Biopsies: bronchoscopic technique and sampling.
Robinson DS, Faurschou P, Barnes N, Adelroth E. Robinson DS, et al. Among authors: adelroth e. Eur Respir J Suppl. 1998 Mar;26:16S-19S. Eur Respir J Suppl. 1998. PMID: 9585874 Review. No abstract available.
Bronchial provocation with leukotrienes and other stimuli.
O'Byrne PM, Adelroth E, Manning PJ. O'Byrne PM, et al. Among authors: adelroth e. Adv Prostaglandin Thromboxane Leukot Res. 1994;22:207-15. Adv Prostaglandin Thromboxane Leukot Res. 1994. PMID: 7771334 Review. No abstract available.
45 results